COGENT STRATEGIES LLC for RELX INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
S.1003 - A bill to amend title XIX of the Social Security Act to add standards for drug compendia for physician use for purposes of Medicaid payment for certain drugs, and for other purposes. H.R.4174/S. 2046 - Foundations for Evidence-Based Policymaking Act of 2017
Foreign entity interest: As a foreign entity listed on Line 14 of the LD-1 registration, RELX Group has an interest in the issues above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID ADAMS | — |
| CLAUDIA JAMES | — |
| ANDREW KAUDERS | — |
| KEVIN MCLAUGHLIN | — |
Copyright/Patent/Trademark CPT
Issues related to scientific, technical, and medical publishing. S.1701/HR 3427 - Fair Access to Science and Technology Research Act of 2017. S. 760 - Open, Public, Electronic, and Necessary Government Data Act or the OPEN Government Data Act (licensing and copyright provisions).
Foreign entity interest: As a foreign entity listed on Line 14 of the LD-1 registration, RELX Group has an interest in the issues above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID ADAMS | — |
| CLAUDIA JAMES | — |
| ANDREW KAUDERS | — |
| KEVIN MCLAUGHLIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.